Incidence, serogroups and case-fatality rate of invasive meningococcal infections in a Swedish region 1975-1989.

In a retrospective study of invasive meningococcal infections in Greater Gothenburg, Sweden, 213 cases of culture-verified meningitis or septicaemia were identified during the 15-year period 1975-1989. The annual incidence was 2.0/100,000. Cases were seen in all age-groups with the highest rates in the 0-4 and 15-19 year-old groups, 9.5 and 6.2/100,000 respectively. 20% of the patients were less than 2 years. 91% of the patients had no known risk factors. In only 10 cases (5%) was contact with another case of meningococcal infection known. The main clinical manifestations were meningitis (57%), septicaemia with no sign of focal infection (25%) and septic shock (17%). The case-fatality rate for all the patients was 6.6% and did not change during the 15-year period. One-third of the patients who presented with septic shock died. The serogroup was known for strains from 192 patients. 51% of the strains belonged to serogroup B, 10% to group A and 23% to group C. In conclusion, the incidence of meningococcal infection was low but the relatively high case-fatality rate warrants a search for effective prophylaxis. About 30% of the cases were potentially preventable by the currently available tetravalent (A, C, Y and W135) polysaccharide vaccine, which is immunogenic in children greater than 2 years. Widespread use of antibiotic prophylaxis to close contacts of known cases would not lower the incidence markedly.

[1]  W. M. Shepherd,et al.  Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins. , 1991, Vaccine.

[2]  T. S. Tang,et al.  Fatal coxsackie B1 virus infection in neonates , 1989, The Pediatric infectious disease journal.

[3]  Varughese Pv Meningococcal disease in Canada: surveillance summary to 1987. , 1989 .

[4]  W. Hitchcock,et al.  Meningococcal infections in children: a review of 100 cases. , 1989, The Pediatric infectious disease journal.

[5]  D. Lennon,et al.  An outbreak of meningococcal disease in Auckland, New Zealand. , 1989, The Pediatric infectious disease journal.

[6]  A. Sjöholm,et al.  Another Swedish family with complete properdin deficiency: association with fulminant meningococcal disease in one male family member. , 1989, Scandinavian journal of infectious diseases.

[7]  P. Magnussen,et al.  Complement deficiencies in selected groups of patients with meningococcal disease. , 1989, Scandinavian journal of infectious diseases.

[8]  S. Harthug,et al.  Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection , 1988, Journal of clinical microbiology.

[9]  B. Claesson,et al.  Haemophilus influenzae meningitis in Sweden 1981-1983. , 1987, Archives of disease in childhood.

[10]  I. Brandslund,et al.  Screening for complement deficiencies in unselected patients with meningitis. , 1987, Clinical and experimental immunology.

[11]  P. Olcén,et al.  Increased incidence of childhood bacterial meningitis. A 25-year study in a defined population in Sweden. , 1987, Scandinavian journal of infectious diseases.

[12]  J. Winkelstein,et al.  Prevalence of complement deficiencies in children with systemic meningococcal infections. , 1987, The Pediatric infectious disease journal.

[13]  A. Halstensen,et al.  Case fatality of meningococcal disease in western Norway. , 1987, Scandinavian journal of infectious diseases.

[14]  H. Zanen,et al.  MENINGOCOCCAL SEROTYPES AND SEROGROUP B DISEASE IN NORTH-WEST EUROPE , 1986, The Lancet.

[15]  C. Adamsbaum,et al.  AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINE , 1985, The Lancet.

[16]  R. Norrby,et al.  Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. , 1985, Reviews of infectious diseases.

[17]  M. Lepow,et al.  Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report. , 1983, The New England journal of medicine.

[18]  H. Peltola Meningococcal disease: still with us. , 1983, Reviews of infectious diseases.

[19]  H. Peltola,et al.  Meningococcal disease in Scandinavia. , 1982, British medical journal.

[20]  B. Greenwood,et al.  Is there a genetic immune defect in families with meningococcal meningitis? , 1981, The Journal of infection.

[21]  E. Gotschlich,et al.  Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. , 1977, Pediatrics.